GC Cell's ImmunCell-LC Injection Officially Listed in WHO Antineoplastic Cell and Gene Therapy Classification
GC Cell announced on July 9 that its immune cell therapy, ImmunCell-LC Injection, has been officially approved for listing in the "Antineoplastic cell and gene therapy (L01XL)" category under the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system.
Previously, due to the lack of a clear classification system for cell therapies, ImmunCell-LC Injection had been categorized as "Other immunostimulants (L03AX)." However, after the WHO established and reorganized the "Antineoplastic cell and gene therapy (L01XL)" category, the product underwent a review process and its inclusion in this category was confirmed. The official listing date for ImmunCell-LC Injection (L01XL17) within this classification is set for January next year.
The WHO ATC classification system is an international standard used for the classification and statistical management of pharmaceuticals worldwide. With this listing, ImmunCell-LC Injection will now be included in the international standard classification for cell and gene therapy products, providing a basis for more clearly explaining the product's characteristics during overseas technology exports and global market expansion.
Meanwhile, GC Cell completed the first patient administration of ImmunCell-LC Injection in Indonesia this past May. Building on the success in Indonesia, the company is expanding its overseas business by negotiating additional technology export deals with multiple countries.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A GC Cell representative stated, "The recent inclusion of ImmunCell-LC Injection in the WHO pharmaceutical classification system demonstrates that its clinical trial and real-world data (RWD) meet global standard classification criteria," adding, "With the classification now clearly defined as an anticancer drug, we will continue to pursue overseas expansion and technology exports in line with the final implementation scheduled for 2027."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.